臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

???ui.leftmenu.abouttair???
	???ui.leftmenu.explanation???

???ui.leftmenu.bartitle???
	Repositories
	Author
	Title
	Date
	???ui.leftmenu.statisticschart???
	???ui.leftmenu.realtimefacts???
	???ui.leftmenu.trend???

???index.news???
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

???ui.leftmenu.copyrighttitle???
	???ui.leftmenu.copyrightpublisher???
	???ui.leftmenu.copyrightconference???

???ui.leftmenu.link???
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"pei jer chen"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1???	???jsp.browse.items-by-author.order2???

Showing items 546-595 of 883 (18 Page(s) Totally)
<< < 6 7 8 9 10 11 12 13 14 15 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
臺大學術典藏	2021-07-03T03:34:02Z	Advanced hepatic fibrosis and steatosis are associated with persistent alanine aminotransferase elevation in chronic hepatitis C patients negative for hepatitis C virus RNA during pegylated interferon plus ribavirin therapy	Liang C.-C.; Liu C.-H.; Chung C.-S.; Lin C.-K.; Su T.-H.; Yang H.-C.; Liu C.-J.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-07-03T03:34:02Z	Higher lifetime chance of spontaneous surface antigen loss in hepatitis B carriers with genotype C infection	Tseng T.-C.; Liu C.-J.; Chen C.-L.; Yang W.-T.; Yang H.-C.; Su T.-H.; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-07-03T03:34:02Z	Comparison of abbott realtime HCV genotype II with versant line probe assay 2.0 for hepatitis C virus genotyping	Liu C.-H.; Liang C.-C.; Liu C.-J.; Lin C.-L.; Su T.-H.; Yang H.-C.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-07-03T03:34:01Z	Rapid fluorescent lateral-flow immunoassay for hepatitis B virus genotyping	Song L.-W.; Wang Y.-B.; Fang L.-L.; Wu Y.; Yang L.; Chen J.-Y.; Ge S.-X.; Zhang J.; Xiong Y.-Z.; Deng X.-M.; Min X.-P.; Zhang J.; PEI-JER CHEN; Yuan Q.; Xia N.-S.
臺大學術典藏	2021-07-03T03:34:01Z	Predicting hepatitis B virus (HBV) surface antigen seroclearance in HBV e antigen-negative patients with chronic hepatitis B: External validation of a scoring system	Liu J.; Tseng T.-C.; Yang H.-I.; Lee M.-H.; Batrla-Utermann R.; Jen C.-L.; Lu S.-N.; Wang L.-Y.; You S.-L.; PEI-JER CHEN; Chen C.-J.; Kao J.-H.
臺大學術典藏	2021-07-03T03:34:01Z	Tumor necrosis factor-alpha blockage therapy impairs hepatitis B viral clearance and enhances T-cell exhaustion in a mouse model	Chyuan I.-T.; Tsai H.-F.; Tzeng H.-T.; Sung C.-C.; Wu C.-S.; PEI-JER CHEN; Hsu P.-N.
臺大學術典藏	2021-07-03T03:34:00Z	Contribution of adiponectin and its type 1 receptor to age-related hearing impairment	Wu C.-C.; Tsai C.-H.; Lu Y.-C.; Lin H.-C.; Hwang J.-H.; Lin Y.-H.; Yang W.-S.; PEI-JER CHEN; Liao W.-C.; Lee Y.L.; Liu T.-C.; Hsu C.-J.
臺大學術典藏	2021-07-03T03:34:00Z	Feedback regulation of IFN-α/β signaling by Axl receptor tyrosine kinase modulates HBV immunity	Huang M.-T.; Liu W.-L.; Lu C.-W.; Huang J.-J.; Chuang H.-L.; Huang Y.-T.; Horng J.-H.; Liu P.; Han D.-S.; Chiang B.-L.; Shih C.; PEI-JER CHEN; Chen D.-S.
臺大學術典藏	2021-07-03T03:34:00Z	Development of risk scoring system for stratifying population for hepatocellular carcinoma screening	Hung Y.-C.; Lin C.-L.; Liu C.-J.; Hung H.; Lin S.-M.; Lee S.-D.; PEI-JER CHEN; Chuang S.-C.; Yu M.-W.
臺大學術典藏	2021-07-03T03:33:59Z	Gender disparity in chronic hepatitis B: Mechanisms of sex hormones	Wang S.-H.; PEI-JER CHEN; Yeh S.-H.
臺大學術典藏	2021-07-03T03:33:59Z	Peginterferon plus weight-based ribavirin for treatment-na?ve hepatitis C virus genotype 2 patients not achieving rapid virologic response: A randomized trial	Liu C.-H.; Huang C.-F.; Liu C.-J.; Dai C.-Y.; Huang J.-F.; Lin J.-W.; Liang C.-C.; Yang S.-S.; Lin C.-L.; Su T.-H.; Yang H.-C.; PEI-JER CHEN; Chen D.-S.; Chuang W.-L.; Kao J.-H.; Yu M.-L.
臺大學術典藏	2021-07-03T03:33:59Z	Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition	Su T.-H.; Shiau C.-W.; Jao P.; Liu C.-H.; Liu C.-J.; Tai W.-T.; Jeng Y.-M.; Yang H.-C.; Tseng T.-C.; Huang H.-P.; Cheng H.-R.; PEI-JER CHEN; Chen K.-F.; Kao J.-H.; Chen D.-S.
臺大學術典藏	2021-07-03T03:33:58Z	Global patterns of hepatocellular carcinoma management from diagnosis to death: The BRIDGE Study	Park J.-W.; Chen M.; Colombo M.; Roberts L.R.; Schwartz M.; PEI-JER CHEN; Kudo M.; Johnson P.; Wagner S.; Orsini L.S.; Sherman M.
臺大學術典藏	2021-07-03T03:33:58Z	Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers	Tseng T.-C.; Liu C.-J.; Yang H.-C.; Chen C.-L.; Yang W.-T.; Tsai C.-S.; Kuo S.F.-T.; Verbree F.C.; Su T.-H.; Wang C.-C.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-07-03T03:33:58Z	Treatment of liver cancer	Liu C.-Y.; Chen K.-F.; PEI-JER CHEN
臺大學術典藏	2021-07-03T03:33:58Z	Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: A randomised trial	Liu C.-H.; Liu C.-J.; Huang C.-F.; Lin J.-W.; Dai C.-Y.; Liang C.-C.; Huang J.-F.; Hung P.-H.; Tsai H.-B.; Tsai M.-K.; Lee C.-Y.; Chen S.-I.; Yang S.-S.; Su T.-H.; Yang H.-C.; PEI-JER CHEN; Chen D.-S.; Chuang W.-L.; Yu M.-L.; Kao J.-H.
臺大學術典藏	2021-07-03T03:33:57Z	Linifanib versus sorafenib in patients with advanced hepatocellular carcinoma: Results of a randomized phase III trial	Cainap C.; Qin S.; Huang W.-T.; Chung I.J.; Pan H.; Cheng Y.; Kudo M.; Kang Y.-K.; PEI-JER CHEN; Toh H.-C.; Gorbunova V.; Eskens F.A.L.M.; Qian J.; McKee M.D.; Ricker J.L.; Carlson D.M.; El-Nowiem S.
臺大學術典藏	2021-07-03T03:33:57Z	Sorafenib Action in Hepatitis B Virus X-Activated Oncogenic Androgen Pathway in Liver Through SHP-1	Wang S.-H.; Yeh S.-H.; Shiau C.-W.; Chen K.-F.; Lin W.-H.; Tsai T.-F.; Teng Y.-C.; Chen D.-S.; PEI-JER CHEN
臺大學術典藏	2021-07-03T03:33:57Z	Use of HLA-B?58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: National prospective cohort study	Ko T.-M.; Tsai C.-Y.; Chen S.-Y.; Chen K.-S.; Yu K.-H.; Chu C.-S.; Huang C.-M.; Wang C.-R.; Weng C.-T.; Yu C.-L.; Hsieh S.-C.; Tsai J.-C.; Lai W.-T.; Tsai W.-C.; Yin G.-D.; Ou T.-T.; Cheng K.-H.; Yen J.-H.; Liou T.-L.; Lin T.-H.; Chen D.-Y.; Hsiao P.-J.; Weng M.-Y.; Chen Y.-M.; Chen C.-H.; Liu M.-F.; Yen H.-W.; Lee J.-J.; Kuo M.-C.; Wu C.-C.; Hung S.-Y.; Luo S.-F.; Yang Y.-H.; Chuang H.-P.; Chou Y.-C.; Liao H.-T.; Wang C.-W.; Huang C.-L.; Chang C.-S.; Lee M.-T.M.; PEI-JER CHEN; Wong C.-S.; Chen C.-H.; Wu J.-Y.; Chen Y.-T.; Shen C.-Y.
臺大學術典藏	2021-07-03T03:33:56Z	Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Na?ve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial	Liu C.-H.; Huang C.-F.; Liu C.-J.; Dai C.-Y.; Huang J.-F.; Lin J.-W.; Liang C.-C.; Yang S.-S.; Lin C.-L.; Su T.-H.; Yang H.-C.; PEI-JER CHEN; Chen D.-S.; Chuang W.-L.; Kao J.-H.; Yu M.-L.
臺大學術典藏	2021-07-03T03:33:56Z	Chronic Hepatitis B virus infection	Yuen M.-F.;Ahn S.H.;Chen D.-S.;Pei-Jer Chen;Dusheiko G.M.;Hou J.-L.;Maddrey W.C.;Mizokami M.;Seto W.-K.;Zoulim F.;Lai C.-L.; Yuen M.-F.; Ahn S.H.; Chen D.-S.; PEI-JER CHEN; Dusheiko G.M.; Hou J.-L.; Maddrey W.C.; Mizokami M.; Seto W.-K.; Zoulim F.; Lai C.-L.
臺大學術典藏	2021-07-03T03:33:56Z	Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naive Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study	Liu C.-H.; Sheng W.-H.; Sun H.-Y.; Hsieh S.-M.; Lo Y.-C.; Liu C.-J.; Su T.-H.; Yang H.-C.; Liu W.-C.; PEI-JER CHEN; Chen D.-S.; Hung C.-C.; Kao J.-H.
臺大學術典藏	2021-07-03T03:33:55Z	Characterization of metastatic tumor antigen 1 and its interaction with hepatitis B virus X protein in NF-κB signaling and tumor progression in a woodchuck hepatocellular carcinoma model	Li Y.-T.;Liu C.-J.;Su T.-H.;Cheng H.-R.;Jeng Y.-M.;Lin H.-L.;Wang C.-C.;Kao J.-H.;Pei-Jer Chen;Chen D.-S.;Wu H.-L.; Li Y.-T.; Liu C.-J.; Su T.-H.; Cheng H.-R.; Jeng Y.-M.; Lin H.-L.; Wang C.-C.; Kao J.-H.; PEI-JER CHEN; Chen D.-S.; Wu H.-L.
臺大學術典藏	2021-07-03T03:33:55Z	Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update	Sarin S.K.;Kumar M.;Lau G.K.;Abbas Z.;Chan H.L.Y.;Chen C.J.;Chen D.S.;Chen H.L.;Pei-Jer Chen;Chien R.N.;Dokmeci A.K.;Gane E.;Hou J.L.;Jafri W.;Jia J.;Kim J.H.;Lai C.L.;Lee H.C.;Lim S.G.;Liu C.J.;Locarnini S.;Al Mahtab M.;Mohamed R.;Omata M.;Park J.;Piratvisuth T.;Sharma B.C.;Sollano J.;Wang F.S.;Wei L.;Yuen M.F.;Zheng S.S.;Kao J.H.; Sarin S.K.; Kumar M.; Lau G.K.; Abbas Z.; Chan H.L.Y.; Chen C.J.; Chen D.S.; Chen H.L.; PEI-JER CHEN; Chien R.N.; Dokmeci A.K.; Gane E.; Hou J.L.; Jafri W.; Jia J.; Kim J.H.; Lai C.L.; Lee H.C.; Lim S.G.; Liu C.J.; Locarnini S.; Al Mahtab M.; Mohamed R.; Omata M.; Park J.; Piratvisuth T.; Sharma B.C.; Sollano J.; Wang F.S.; Wei L.; Yuen M.F.; Zheng S.S.; Kao J.H.
臺大學術典藏	2021-07-03T03:33:54Z	Hepatitis C viral infection increases the risk of lymphoid-neoplasms: A population-based cohort study	Su T.-H.;Liu C.-J.;Tseng T.-C.;Chou S.-W.;Liu C.-H.;Yang H.-C.;Wu S.-J.;Pei-Jer Chen;Chen D.-S.;Chen C.-L.;Kao J.-H.; Su T.-H.; Liu C.-J.; Tseng T.-C.; Chou S.-W.; Liu C.-H.; Yang H.-C.; Wu S.-J.; PEI-JER CHEN; Chen D.-S.; Chen C.-L.; Kao J.-H.
臺大學術典藏	2021-07-03T03:33:54Z	Hepatocellular carcinoma and hepatitis C virus	Wang S.-H.;Yeh S.-H.;Pei-Jer Chen; Wang S.-H.; Yeh S.-H.; PEI-JER CHEN
臺大學術典藏	2021-07-03T03:33:53Z	Prolonged suppression of HBV in mice by a novel antibody that targets a unique epitope on hepatitis B surface antigen	Zhang T.-Y.;Yuan Q.;Zhao J.-H.;Zhang Y.-L.;Yuan L.-Z.;Lan Y.;Lo Y.-C.;Sun C.-P.;Wu C.-R.;Zhang J.-F.;Zhang Y.;Cao J.-L.;Guo X.-R.;Liu X.;Mo X.-B.;Luo W.-X.;Cheng T.;Chen Y.-X.;Tao M.-H.;Shih J.W.K.;Zhao Q.-J.;Zhang J.;Pei-Jer Chen;Yuan Y.A.;Xia N.-S.; Zhang T.-Y.; Yuan Q.; Zhao J.-H.; Zhang Y.-L.; Yuan L.-Z.; Lan Y.; Lo Y.-C.; Sun C.-P.; Wu C.-R.; Zhang J.-F.; Zhang Y.; Cao J.-L.; Guo X.-R.; Liu X.; Mo X.-B.; Luo W.-X.; Cheng T.; Chen Y.-X.; Tao M.-H.; Shih J.W.K.; Zhao Q.-J.; Zhang J.; PEI-JER CHEN; Yuan Y.A.; Xia N.-S.
臺大學術典藏	2021-07-03T03:33:53Z	Health-related quality of life in thrombocytopenic patients with chronic hepatitis C with or without cirrhosis in the ENABLE-1 and ENABLE-2 studies	Grotzinger K.M.;Younossi Z.M.;Giannini E.G.;Pei-Jer Chen;Rendas-Baum R.;Theodore D.; Grotzinger K.M.; Younossi Z.M.; Giannini E.G.; PEI-JER CHEN; Rendas-Baum R.; Theodore D.
臺大學術典藏	2021-07-03T03:33:53Z	Hepatitis B surface antigen loss and hepatocellular carcinoma development in patients with dual hepatitis B and C infection	Yang W.-T.;Wu L.-W.;Tseng T.-C.;Chen C.-L.;Yang H.-C.;Su T.-H.;Wang C.-C.;Kuo S.F.-T.;Liu C.-H.;Pei-Jer Chen;Chen D.-S.;Liu C.-J.;Kao J.-H.; Yang W.-T.; Wu L.-W.; Tseng T.-C.; Chen C.-L.; Yang H.-C.; Su T.-H.; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Liu C.-J.; Kao J.-H.
臺大學術典藏	2021-07-03T03:33:52Z	Perspectives on dual hepatitis B and C infection in Taiwan	Liu C.-J.;Pei-Jer Chen;Chen D.-S.;Tseng T.-C.;Kao J.-H.; Liu C.-J.; PEI-JER CHEN; Chen D.-S.; Tseng T.-C.; Kao J.-H.
臺大學術典藏	2021-07-03T03:33:52Z	Peginterferon lambda for the treatment of HBeAg-positive chronic hepatitis B: A randomized phase 2b study (LIRA-B)	Chan H.L.Y.;Ahn S.H.;Chang T.-T.;Peng C.-Y.;Wong D.;Coffin C.S.;Lim S.G.;Pei-Jer Chen;Janssen H.L.A.;Marcellin P.;Serfaty L.;Zeuzem S.;Cohen D.;Critelli L.;Xu D.;Wind-Rotolo M.;Cooney E.;Lira-B Study Team; Chan H.L.Y.; Ahn S.H.; Chang T.-T.; Peng C.-Y.; Wong D.; Coffin C.S.; Lim S.G.; PEI-JER CHEN; Janssen H.L.A.; Marcellin P.; Serfaty L.; Zeuzem S.; Cohen D.; Critelli L.; Xu D.; Wind-Rotolo M.; Cooney E.; LIRA-B Study Team
臺大學術典藏	2021-07-03T03:33:52Z	The Hepatitis Viral Status in Patients with Hepatocellular Carcinoma: A Study of 3843 Patients from Taiwan Liver Cancer Network	Chang I.-C.;Huang S.-F.;Pei-Jer Chen;Chen C.-L.;Chen C.-L.;Wu C.-C.;Tsai C.-C.;Lee P.-H.;Chen M.-F.;Lee C.-M.;Yu H.-C.;Lo G.-H.;Yeh C.-T.;Hong C.-C.;Eng H.-L.;Wang J.;Tseng H.-H.;Hsiao C.-H.;Wu H.-D.I.;Yen T.-C.;Liaw Y.-F.; Chang I.-C.; Huang S.-F.; PEI-JER CHEN; Chen C.-L.; Chen C.-L.; Wu C.-C.; Tsai C.-C.; Lee P.-H.; Chen M.-F.; Lee C.-M.; Yu H.-C.; Lo G.-H.; Yeh C.-T.; Hong C.-C.; Eng H.-L.; Wang J.; Tseng H.-H.; Hsiao C.-H.; Wu H.-D.I.; Yen T.-C.; Liaw Y.-F.
臺大學術典藏	2021-07-03T03:33:51Z	Hypoxia-activated cytotoxic agent tirapazamine enhances hepatic artery ligation-induced killing of liver tumor in HBx transgenic mice	Lin W.-H.;Yeh S.-H.;Yeh K.-H.;Chen K.-W.;Cheng Y.-W.;Su T.-H.;Jao P.;Ni L.-C.;Pei-Jer Chen;Chen D.-S.; Lin W.-H.; Yeh S.-H.; Yeh K.-H.; Chen K.-W.; Cheng Y.-W.; Su T.-H.; Jao P.; Ni L.-C.; PEI-JER CHEN; Chen D.-S.
臺大學術典藏	2021-07-03T03:33:51Z	Progressive accumulation of mutations in the hepatitis B virus genome and its impact on time to diagnosis of hepatocellular carcinoma	Sung F.-Y.;Lan C.-Y.;Huang C.-J.;Lin C.-L.;Liu C.-J.;Pei-Jer Chen;Lin S.-M.;Yu M.-W.; Sung F.-Y.; Lan C.-Y.; Huang C.-J.; Lin C.-L.; Liu C.-J.; PEI-JER CHEN; Lin S.-M.; Yu M.-W.
臺大學術典藏	2021-07-03T03:33:51Z	Liver gene expression profiles correlate with virus infection and response to interferon therapy in chronic hepatitis B patients	Wu H.-L.;Hsiao T.-H.;Pei-Jer Chen;Wong S.-H.;Kao J.-H.;Chen D.-S.;Lu J.-Y.;Lu T.-P.;Chen Y.;Chuang E.Y.;Tu H.-C.;Liu C.-J.; Wu H.-L.; Hsiao T.-H.; PEI-JER CHEN; Wong S.-H.; Kao J.-H.; Chen D.-S.; Lu J.-Y.; Lu T.-P.; Chen Y.; Chuang E.Y.; Tu H.-C.; Liu C.-J.
臺大學術典藏	2021-07-03T03:33:50Z	A novel toolbox for the in vitro assay of hepatitis D virus infection	Zhao J.-H.; Zhang Y.-L.; Zhang T.-Y.; Yuan L.-Z.; Cheng T.; PEI-JER CHEN; Yuan Q.; Xia N.-S.
臺大學術典藏	2021-07-03T03:33:50Z	Management of hepatitis C virus infection in the Asia-Pacific region: an update	Lim S.G.; Aghemo A.; PEI-JER CHEN; Dan Y.Y.; Gane E.; Gani R.; Gish R.G.; Guan R.; Jia J.D.; Lim K.; Piratvisuth T.; Shah S.; Shiffman M.L.; Tacke F.; Tan S.S.; Tanwandee T.; Win K.M.; Yurdaydin C.
臺大學術典藏	2021-07-03T03:33:50Z	Hydrodynamic HBV transfection mouse model	Wu L.-L.; Wang H.-Y.; PEI-JER CHEN
臺大學術典藏	2021-07-03T03:33:50Z	Prevalence and clinical implications of IL28B genotypes in Taiwanese patients with chronic hepatitis C	Mah Y.-H.;Liu C.-H.;Chen C.-L.;Tseng T.-C.;Liu C.-J.;Pei-Jer Chen;Chen D.-S.;Kao J.-H.; Mah Y.-H.; Liu C.-H.; Chen C.-L.; Tseng T.-C.; Liu C.-J.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-07-03T03:33:49Z	One-Pot Two-Nanoprobe Assay Uncovers Targeted Glycoprotein Biosignature	Chen Y.-J.; Dela Rosa M.A.C.; Chen W.-C.; Chen Y.-J.; Obena R.P.; Chang C.-H.; Capangpangan R.Y.; Su T.-H.; Chen C.-L.; PEI-JER CHEN
臺大學術典藏	2021-07-03T03:33:49Z	Addition of ribavirin to daclatasvir plus asunaprevir for chronic hepatitis C 1b patients with baseline NS5A resistance-associated variants improved response	Hong C.-M.; Liu C.-J.; Yeh S.-H.; PEI-JER CHEN
臺大學術典藏	2021-07-03T03:33:49Z	Corrigendum to “Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma” (Journal of Hepatology (2011) 55(5) (1041–1048)(S0168827811001917)(10.1016/j.jhep.2011.01.047))	Tai W.-T.; Cheng A.-L.; Shiau C.-W.; Huang H.-P.; Huang J.-W.; PEI-JER CHEN; Chen K.-F.
臺大學術典藏	2021-07-03T03:33:49Z	Genome-wide identification of blood DNA methylation patterns associated with early-onset hepatocellular carcinoma development in hepatitis B carriers	Kao W.-Y.; Yang S.-H.; Liu W.-J.; Yeh M.-Y.; Lin C.-L.; Liu C.-J.; Huang C.-J.; Lin S.-M.; Lee S.-D.; PEI-JER CHEN; Yu M.-W.
臺大學術典藏	2021-07-03T03:33:48Z	A phase I/II multicenter study of single-agent foretinib as first-line therapy in patients with advanced hepatocellular carcinoma	Yau T.C.C.; Lencioni R.; Sukeepaisarnjaroen W.; Chao Y.; Yen C.-J.; Lausoontornsiri W.; PEI-JER CHEN; Sanpajit T.; Camp A.; Cox D.S.; Gagnon R.C.; Liu Y.; Raffensperger K.E.; Kulkarni D.A.; Kallender H.; Ottesen L.H.; Poon R.T.P.; Bottaro D.P.
臺大學術典藏	2021-07-03T03:33:48Z	De novo assembly of highly polymorphic metagenomic data using in situ generated reference sequences and a novel BLAST-based assembly pipeline	Lin Y.-Y.; Hsieh C.-H.; Chen J.-H.; Lu X.; Kao J.-H.; PEI-JER CHEN; Chen D.-S.; Wang H.-Y.
臺大學術典藏	2021-07-03T03:33:48Z	Prescription patterns of sorafenib and outcomes of patients with advanced hepatocellular carcinoma: A national population study	Lu L.-C.; PEI-JER CHEN; Yeh Y.-C.; Hsu C.-H.; Chen H.-M.; Lai M.-S.; Shao Y.-Y.; Cheng A.-L.
臺大學術典藏	2021-07-03T03:33:47Z	Corrigendum to “Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma” (Journal of Hepatology (2017) 66(3) (666–668) (S0168827816307127) (10.1016/j.jhep.2016.12.007))	Tai W.-T.; Cheng A.-L.; Shiau C.-W.; Huang H.-P.; Huang J.-W.; PEI-JER CHEN; Chen K.-F.
臺大學術典藏	2021-07-03T03:33:47Z	Chronologic changes in serum hepatitis B virus DNA, genotypes, surface antigen mutants and reverse transcriptase mutants during 25-year nationwide immunization in Taiwan	Hsu H.-Y.; Chang M.-H.; Ni Y.-H.; Chiang C.-L.; Wu J.-F.; Chen H.-L.; PEI-JER CHEN; Chen D.-S.
臺大學術典藏	2021-07-03T03:33:47Z	Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update	Omata M.; Cheng A.-L.; Kokudo N.; Kudo M.; Lee J.M.; Jia J.; Tateishi R.; Han K.-H.; Chawla Y.K.; Shiina S.; Jafri W.; Payawal D.A.; Ohki T.; Ogasawara S.; PEI-JER CHEN; Lesmana C.R.A.; Lesmana L.A.; Gani R.A.; Obi S.; Dokmeci A.K.; Sarin S.K.
臺大學術典藏	2021-07-03T03:33:47Z	Peg-interferon lambda treatment induces robust innate and adaptive immunity in chronic hepatitis B patients	Phillips S.; Mistry S.; Riva A.; Cooksley H.; Hadzhiolova-Lebeau T.; Plavova S.; Katzarov K.; Simonova M.; Zeuzem S.; Woffendin C.; PEI-JER CHEN; Peng C.-Y.; Chang T.-T.; Lueth S.; Knegt R.D.; Choi M.-S.; Wedemeyer H.; Dao M.; Kim C.-W.; Chu H.-C.; Wind-Rotolo M.; Williams R.; Cooney E.; Chokshi S.

Showing items 546-595 of 883 (18 Page(s) Totally)
<< < 6 7 8 9 10 11 12 13 14 15 > >>
View [10|25|50] records per page

	English \| 正體中文 \| 简体中文 \| 0
	???header.visitor??? : 51779709 ???header.onlineuser??? : 1158 ???header.sponsordeclaration???